Search Results
The Leukemia & Lymphoma Society's New Chief Scientific Officer Excited about What's Next in Blood Cancer Research
Lore Gruenbaum, Ph.D., was promoted to The Leukemia & Lymphoma Society’s (LLS) Chief Scientific Officer (CSO) following the retirement of longtime CSO Lee Greenberger, Ph.D. on December 31. We talked with Dr. Gruenbaum about her new role and what’s on the horizon for blood cancer research in 2025.
“It’s a privilege to lead a group of dedicated LLS scientists to seek out and fund innovative science for every type of blood cancer,” says Dr. Gruenbaum.
Because You Volunteer, Your Impact Creates a Ripple Effect
When you commit time and talent to a nonprofit’s mission – no matter how you choose to get involved – you become a volunteer, and the impact of your efforts runs far deeper than the specific project or task you work on. For example, volunteers don’t always realize that the hours they spent stocking shelves meant hundreds of families would have food for two weeks. Or that the time spent fundraising not only raised critical mission dollars but also added value upward of $1,250 to the organization’s bottom line.
FDA Approves First CAR T-Immunotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
The U.S. Food and Drug Administration (FDA) recently announced approval of brexucabtagene autoleucel (Tecartus®) as the first and only CAR T-cell treatment for adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). Roughly half of all ALL cases occur in adults, and unlike pediatric ALL, adults have historically had a poor prognosis. This approval, which follows an FDA Breakthrough Therapy Designation and priority review, is a meaningful advance for these patients.
Helping Survivors Lead Longer Better Lives
Late last year I had the privilege of attending a special screening of the documentary American Symphony. The film chronicles the experiences of writer Suleika Jaouad and her husband musician Jon Batiste after learning that her acute myeloid leukemia (AML) had returned after years of remission. The movie shows how the couple navigates uncertainty, treatment, and their new normal afterwards.
SAVE THE DATE AGAIN: GETTING MARRIED AFTER CANCER
My name’s Dustin. December 3, 2016 was the date that I was supposed to get married to KT. It was a Saturday. We had that date set for over a year, but there was no wedding—we canceled it the Tuesday before. KT informed most of our guests with an explanatory text: “So, I have some unfortunate news. We’re going to have to call off the wedding this weekend. Dust got cold feet…and leukemia.”
Blood Cancer Research Poised for Another ‘Banner Year’ in 2024
More than 25,000 medical professionals from across the world came together in December to discuss the latest blood cancer developments during the annual meeting of the American Society of Hematology (ASH). This annual event gives us the opportunity to think about what advances are on the horizon as LLS works to strengthen cures, care and quality of life for people with blood cancer and their families.
Exercise for blood cancer patients
Table of contents:
Improving Blood Cancer Survival Takes More than New Drug Discovery
In my years as a practicing hematologist-oncologist and now as chief medical officer of The Leukemia & Lymphoma Society (LLS), I’ve met many blood cancer patients who worry about how they’ll afford their treatment on top of day-to-day expenses like rent and groceries. LLS offers financial assistance for qualifying blood cancer patients and families
What Is Blood Cancer?
Reviewed by Gwen Nichols, MD, EVP and Chief Medical Officer at The Leukemia & Lymphoma Society
Predisposing factors to leukemia
Table of contents:
Finding Support in Community: Walgreens and LLS Show Up for Blood Cancer Patients
We all need a helping hand sometimes.
Add on a cancer diagnosis and the everyday suddenly feels... different. In many ways, harder.
The Gift of Time: Giving More Moments to Blood Cancer Patients
As we transition from one year to the next, we often reflect on milestones achieved, challenges faced, and moments shared with those we love. It’s a time to focus on what’s most important—family, community, and how we’ll spend our time going forward. At the Leukemia & Lymphoma Society (LLS), we know that time is more than just a passing moment for blood cancer patients. It’s the most valuable gift they can receive.
Blood cancers that cause high monocytes: Understanding the connection
Table of contents:
Patience
We were clobbered, like every patient, every family, who gets clobbered with a life-threatening diagnosis.
Jeff
Meet Jeff. Follicular Lymphoma Survivor. During an annual physical, Jeff noticed a lump under his arm, and after a biopsy it was discovered that he had follicular lymphoma. Jeff learned that LLS was doing research in the area of his illness and also received important disease information from LLS. Jeff's wife talks about the innovative treatments that LLS is funding and how, as advancements take place, longevity for Jeff becomes more and more of a reality.
Leukemia vs. lymphoma: What you need to know
Table of contents
LLS Researchers
Partnering for Cures – Our Unique Collaborations Span Continents
5 Reasons why I’m grateful for LLS Volunteers
It’s National Volunteer Week, and I want to thank all our LLS volunteers for the time, energy, and commitment you give to our organization in service of blood cancer patients and their families. Through your many acts of kindness, compassion, and generosity, you are helping patients live longer, better lives. All of us at LLS are so grateful for you—all year long.
Healthcare for Undocumented Persons
In most states, undocumented immigrants are not eligible to enroll in Medicare, Medicaid or Children’s Health Insurance Program (CHIP), or to buy Marketplace health coverage. As of 2024, only Colorado and Washington allow undocumented immigrants to buy individual health insurance from state marketplaces. There may be limited options for coverage for emergency services; however, cancer treatment may not constitute emergency care.